RCC Cements Limited has filed its quarterly Statement of Investor Complaints with the Bombay Stock Exchange for the quarter ended 31st March, 2026. The submission, dated 13th April, 2026, fulfills the company's regulatory obligations under Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Complaint Status Summary

The company reported a clean slate across all complaint categories for the Q4FY26 period. The comprehensive statement reveals zero investor grievances throughout the quarter, indicating smooth investor relations during this period.

Regulatory Compliance

The filing demonstrates RCC Cements Limited's adherence to mandatory disclosure requirements under SEBI regulations. Companies listed on Indian stock exchanges must submit quarterly investor complaint statements to maintain transparency and regulatory compliance. The document was digitally signed by Rachit Garg, Chief Financial Officer, ensuring proper authorization and authenticity.

Company Information

RCC Cements Limited operates with CIN L26942DL2091PLC043776 and maintains its registered office at 702, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi-110001. The company trades on BSE under scrip code 531825 (RCCEMEN). This quarterly disclosure reinforces the company's commitment to maintaining transparent investor relations and regulatory compliance standards.

RCC Cements Limited successfully conducted its mandatory independent directors meeting on March 25, 2026, fulfilling regulatory requirements under corporate governance norms. The meeting represents a key compliance milestone for the company as part of its annual governance processes.

Meeting Details and Compliance

The independent directors meeting was held at the company's registered office located at 702, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi-110001. The session commenced at 05:00 P.M. and concluded at 05:45 P.M., spanning 45 minutes of deliberations.

Key Agenda Items

The independent directors addressed two primary areas of evaluation during their meeting. The directors conducted a comprehensive review of the performance of non-independent directors and assessed the overall effectiveness of the board as a collective body. Additionally, they evaluated the information flow mechanisms between the company's management team and the board of directors.

The meeting agenda focused on:

• Performance review of non-independent directors and board effectiveness
• Assessment of information flow quality, quantity and timeliness between management and board

Regulatory Framework

This meeting was conducted in strict compliance with Regulation 25(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule IV of the Companies Act, 2013. These regulations mandate that independent directors hold separate meetings to evaluate various aspects of board functioning and corporate governance.

The company has duly informed the Bombay Stock Exchange Limited about the meeting outcome, maintaining transparency with stakeholders and ensuring adherence to listing compliance requirements. Chief Financial Officer Rachit Garg signed the regulatory filing, confirming the completion of this mandatory governance exercise for Financial Year 2025-2026.